Expertise in
4
conditions

Jolita C. Bekhof-Hogg

Spaarne Gasthuis
Hoofddorp, NH, NL 
Expertise in
4
conditions
Spaarne Gasthuis
Hoofddorp, NH, NL 

Overview

Jolita Bekhof-Hogg practices practicing medicine in Hoofddorp, Netherlands.

Bekhof-Hogg is highly rated in 4 conditions, according to our data. Their clinical expertise encompasses Newborn Jaundice, Bronchitis, Multisystem Inflammatory Syndrome in Children (MIS-C), and Transient Familial Hyperbilirubinemia.

They are actively involved in clinical research, co-authoring 47 peer reviewed articles and participating in 5 clinical trials.

Locations

Spaarne Gasthuis
Hoofddorp, NH, Netherlands

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

Pediatric Options for Migraine Relief: A Randomized, Double-Blind, Placebo-Controlled Study of Lasmiditan for Acute Treatment of Migraine: PIONEER-PEDS1
Pediatric Options for Migraine Relief: A Randomized, Double-Blind, Placebo-Controlled Study of Lasmiditan for Acute Treatment of Migraine: PIONEER-PEDS1
Enrollment Status: Terminated
Publish Date: September 02, 2026
Intervention Type: Drug
Study Drug: Lasmiditan
Study Phase: Phase 3
A Phase 3, 12-Month, Open-Label Study of Lasmiditan in Pediatric Patients With Migraine - PIONEER-PEDS2
A Phase 3, 12-Month, Open-Label Study of Lasmiditan in Pediatric Patients With Migraine - PIONEER-PEDS2
Enrollment Status: Terminated
Publish Date: June 25, 2026
Intervention Type: Drug
Study Drug: Lasmiditan
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo-Controlled Study of Galcanezumab in Adolescent Patients 12 to 17 Years of Age With Chronic Migraine - the REBUILD-2 Study
A Randomized, Double-Blind, Placebo-Controlled Study of Galcanezumab in Adolescent Patients 12 to 17 Years of Age With Chronic Migraine - the REBUILD-2 Study
Enrollment Status: Active_not_recruiting
Publish Date: February 27, 2026
Intervention Type: Drug
Study Drug: Galcanezumab
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo-Controlled Study of Galcanezumab in Patients 6 to 17 Years of Age With Episodic Migraine - the REBUILD-1 Study
A Randomized, Double-Blind, Placebo-Controlled Study of Galcanezumab in Patients 6 to 17 Years of Age With Episodic Migraine - the REBUILD-1 Study
Enrollment Status: Active_not_recruiting
Publish Date: January 26, 2026
Intervention Type: Drug
Study Phase: Phase 3
High Flow Nasal Cannula Therapy for Infants With Bronchiolitis
High Flow Nasal Cannula Therapy for Infants With Bronchiolitis
Enrollment Status: Completed
Publish Date: May 28, 2020
Intervention Type: Other
Study Phase: Not Applicable
View 4 Less Clinical Trials

47 Total Publications

Oxygen saturation thresholds in children with acute respiratory distress (OxyKids): a multicentre, open, parallel-group, randomised clinical trial.
Oxygen saturation thresholds in children with acute respiratory distress (OxyKids): a multicentre, open, parallel-group, randomised clinical trial.
Journal: The Lancet. Respiratory medicine
Published: February 04, 2026

Frequently Asked Questions about Jolita C. Bekhof-Hogg

Is Jolita C. Bekhof-Hogg a top-rated expert for Newborn Jaundice?

MediFind is an objective health platform that identifies experts based on real-world data. Jolita C. Bekhof-Hogg is classified as an Advanced expert for Newborn Jaundice, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Jolita C. Bekhof-Hogg participate in research or clinical trials?

Yes. Jolita C. Bekhof-Hogg has published 47 articles and abstracts on conditions like Newborn Jaundice. You can view a list of Jolita C. Bekhof-Hogg's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Bekhof-Hogg's expertise for a condition
ConditionClose
      View All 14 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile